Unknown

Dataset Information

Language Delay in Patients with CLN2 Disease: Could It Support Earlier Diagnosis?


ABSTRACT: Neuronal ceroid lipofuscinosis type 2 (CLN2 disease) is a rare pediatric disorder associated with rapid neurodegeneration, and premature death in adolescence. An effective enzyme replacement therapy (cerliponase alfa) has been approved that can reduce this predictable neurological decline. The nonspecific early symptoms of CLN2 disease frequently delay diagnosis and appropriate management. Seizures are generally recognized as the first presenting symptom of CLN2 disease, but emerging data show that language delay may precede this. An improved understanding of language deficits in the earliest stage of CLN2 disease may support the early identification of patients. In this article, CLN2 disease experts examine how language development is affected by CLN2 disease in their clinical practices.

SUBMITTER: Nickel M 

PROVIDER: S-EPMC10643021 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature